Tag: Pharmaceuticals

Navigating Insurance Challenges for High-Cost Cancer Treatments

Explore the complex insurance challenges surrounding high-cost cancer treatments like Keytruda and the legal battles patients face to access essential medications.

TrumpRx Launch: A Step Towards Lower Prescription Drug Costs

Explore the launch of TrumpRx to lower prescription drug costs in the U.S. and its impact on healthcare affordability and reforms.

Transforming Weight Management: The Rise of Oral GLP-1 Medications

Discover how oral GLP-1 medications like Wegovy and Foundayo are transforming healthcare and improving accessibility to weight management solutions.

Minnesota Legislation to Support Hospitals in 340-B Prescription Drug Program

Minnesota's Senate approves a bill to support 340-B hospitals in acquiring discounted medications. Learn about its impact and legislative challenges ahead.

Proposed $35 Insulin Cap Under Private Insurance Highlights Financial Burdens

Explore proposed legislation aiming to cap insulin costs at $35, addressing financial burdens on families managing diabetes. Current healthcare challenges assessed.

Lowering Prescription Drug Costs: The Most Favored Nation Proposal

Explore the MFN proposal to lower prescription drug costs while ensuring healthcare innovation and leadership in America.

Insurance Challenges with GLP-1 Coverage for Weight Loss

Explore the challenges in insurance coverage for GLP-1 weight-loss medications as demand rises and insurers tighten restrictions.

Medicare Part B Payment Adjustments Impacted by Noncovered Drugs

Explore how Medicare Part B payment adjustments for self-administered medications impact beneficiaries and the healthcare market.

UCB Invests in Atlanta Manufacturing; Florida EXTENDS HIV Med Access

UCB's $2B investment in Atlanta and Florida's HIV medication expansion highlight key health industry trends. Explore the impacts and implications for healthcare.

Navigating Alternatives for GLP-1 Medications in Healthcare

Explore innovative pricing models for GLP-1 medications addressing accessibility issues created by insurance denials. Discover direct purchase options and Medicare initiatives.